Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.

Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crinò F, Maruzzelli L, Miraglia R, Floridia G, Vizzini G.

Radiology. 2012 Oct;265(1):124-32. Epub 2012 Aug 13.

PMID:
22891357
2.

Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients.

Girleanu I, Stanciu C, Cojocariu C, Boiculese L, Singeap AM, Trifan A.

Saudi J Gastroenterol. 2014 Sep-Oct;20(5):288-92. doi: 10.4103/1319-3767.141687.

3.

Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis.

John BV, Konjeti R, Aggarwal A, Lopez R, Atreja A, Miller C, Zein NN, Carey WD.

Ann Hepatol. 2013 Nov-Dec;12(6):952-8.

4.

Extrahepatic portal biliopathy: proposed etiology on the basis of anatomic and clinical features.

Walser EM, Runyan BR, Heckman MG, Bridges MD, Willingham DL, Paz-Fumagalli R, Nguyen JH.

Radiology. 2011 Jan;258(1):146-53. doi: 10.1148/radiol.10090923. Epub 2010 Nov 2.

PMID:
21045178
5.

Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.

Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW.

Clin Mol Hepatol. 2014 Dec;20(4):384-91. doi: 10.3350/cmh.2014.20.4.384. Epub 2014 Dec 24.

6.

Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.

Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H.

J Vasc Interv Radiol. 2013 Dec;24(12):1808-16. doi: 10.1016/j.jvir.2013.08.018. Epub 2013 Oct 4.

PMID:
24099787
7.

Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.

Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, Tuzzolino F, Gridelli B, Bosch J.

Gut. 2011 Jun;60(6):846-52. doi: 10.1136/gut.2010.228023. Epub 2011 Feb 28.

PMID:
21357252
8.

A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.

Chen H, Trilok G, Wang F, Qi X, Xiao J, Yang C.

Indian J Med Res. 2014 Feb;139(2):260-6.

9.

Cavernous transformation of portal vein: 16-slice CT portography and correlation with surgical procedure of orthotopic liver transplantation.

Zhang LJ, Yang GF, Jiang B, Wen LQ, Shen W, Qi J.

Abdom Imaging. 2008 Sep-Oct;33(5):529-35. doi: 10.1007/s00261-007-9343-9.

PMID:
18180985
10.

Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.

Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D.

Gastroenterology. 2012 Nov;143(5):1253-60.e1-4. doi: 10.1053/j.gastro.2012.07.018. Epub 2012 Jul 20.

PMID:
22819864
11.

Selective atrophy of the middle hepatic venous drainage area in hepatitis C-related cirrhotic liver: morphometric study by using multidetector CT.

Ozaki K, Matsui O, Kobayashi S, Sanada J, Koda W, Minami T, Kawai K, Gabata T.

Radiology. 2010 Dec;257(3):705-14. doi: 10.1148/radiol.10100468. Epub 2010 Sep 15.

PMID:
20843994
12.

Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.

D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI.

Transplant Proc. 2012 Nov;44(9):2603-5. doi: 10.1016/j.transproceed.2012.09.050.

PMID:
23146469
13.

Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis.

Zhang DL, Hao JY, Yang N.

J Int Med Res. 2013 Jun;41(3):664-72. doi: 10.1177/0300060513483413. Epub 2013 May 1.

PMID:
23637275
14.

Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis.

Li MX, Zhang XF, Liu ZW, Lv Y.

Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):512-9.

15.

Natural history of compensated viral B and D cirrhosis.

Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, Parvulescu I, Constantinescu I.

Rom J Gastroenterol. 2005 Dec;14(4):329-35.

16.

Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.

Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G.

Eur J Gastroenterol Hepatol. 2016 Jan;28(1):82-9. doi: 10.1097/MEG.0000000000000482.

PMID:
26513611
17.

[Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].

Herber S, Pitton M, Mönch C, Schneider J, Manzl N, Kummer I, Kanzler S, Schuchmann M, Junginger T, Düber C, Otto G.

Zentralbl Chir. 2007 Aug;132(4):306-15. German.

PMID:
17724633
18.

Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.

Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC.

Clin Gastroenterol Hepatol. 2012 Jul;10(7):776-83. doi: 10.1016/j.cgh.2012.01.012. Epub 2012 Jan 28.

PMID:
22289875
19.

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.

Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D.

J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.

PMID:
20932597
20.

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A 3rd, Nemcek AA Jr, Gates VL, Abecassis M, Omary RA, Salem R.

Hepatology. 2008 Jan;47(1):71-81.

PMID:
18027884
Items per page

Supplemental Content

Write to the Help Desk